The Role of RNA&nbsp;m6A&nbsp;Methylation in the Regulation of Postnatal Hypoxia-induced Pulmonary Hypertension

doi:10.21203/rs.3.rs-135751/v1

Download PDF

Research

The Role of RNA m⁶A Methylation in the Regulation of Postnatal Hypoxia-induced Pulmonary Hypertension

https://doi.org/10.21203/rs.3.rs-135751/v1

This work is licensed under a CC BY 4.0 License

Journal Publication

published 26 Apr, 2021

Read the published version in Respiratory Research →

You are reading this latest preprint version

Background: Pulmonary hypertension (PH) is a complex pulmonary vascular disease characterized by an imbalance in vasoconstrictor/vasodilator signaling within the pulmonary vasculature. Recent evidence suggests that exposure to hypoxia early in life can cause alterations in the pulmonary vasculature and lead to the development of PH. However, the long-term impact of postnatal hypoxia on lung development and pulmonary function remains unknown. N⁶-methyladenosine (m⁶A) regulates gene expression and governs many important biological processes. However, the function of m⁶A in the development of PH remains poorly characterized. Thus, the purpose of this investigation was to test the two-fold hypothesis that 1) postnatal exposure to hypoxia would alter lung development leading to PH in adult rats, and 2) m⁶A modification would change in rats exposed to hypoxia, suggesting it plays a role in the development of PH.

Methods: Forty male Sprague-Dawley rats were exposed to a hypoxic environment (F_iO₂: 12%) within 24 h after birth for 2 weeks. PH was defined as an increased right ventricular systolic pressure (RVSP) and pathologic changes of pulmonary vasculature measured by α-SMA immunohistochemical staining. Methylated RNA immunoprecipitation sequencing (MeRIP-seq) was performed to analyze m⁶A modification changes in lung tissue between 2 and 9 weeks following exposure to postnatal hypoxia.

Results: mean pulmonary arterial pressure, lung/body weight ratio, and the Fulton index was significantly greater in rats exposed to hypoxia when compared to control and the difference persisted into adulthood. m⁶A methyltransferase and demethylase proteins were significantly downregulated in postnatal hypoxia-induced PH. Distinct m⁶A modification peak-related genes differed between the two groups, and these genes were associated with lung development.

Conclusions: Our results indicate postnatal hypoxia dysregulates lung development, leading to PH, and may have a long-term effect on adult rat lung development via the alterations in pulmonary vasculature function. METTL3, a m⁶A methyltransferase, was elevated in rats exposed to postnatal hypoxia in both the postnatal period and in adulthood, suggesting that it contributes to the development of PH following postnatal hypoxia. Our findings provide new insights into the impact of postnatal hypoxia and the role of m⁶A in the development of pulmonary vascular pathophysiology.

Pulmonology

pulmonary hypertension

postnatal hypoxia

N6-methyladenosine

RNA methylation

Pulmonary hypertension (PH) is a complex pathology regulated by a multitude of molecular pathways and processes. Evidence suggests that postnatal environmental factors can negatively impact the development and physiological status of the pulmonary vasculature ^1–3. These alterations in pulmonary maturation and function could result in the development of PH in adulthood, increase morbidity and mortality, and significantly reduce the quality of life of this population. Previous results from our laboratory revealed that embryonic growth is related to PH and pulmonary vascular function, as intrauterine growth retardation (IUGR) resulted in decreased pulmonary vascular growth ¹ and extrauterine growth retardation (EUGR) was associated with varying degrees of pulmonary arterial hypertension (PAH) later in life ^{1, 3}. These results suggest that environmental factors in early life play a critical role in developing PH and result in long-term ramifications for pulmonary function.

As part of the epigenetic regulation in mammals, RNA modifications, similar to DNA and histone modifications, play an essential role in various physiological and pathological processes ^{4, 5}. More than 100 distinct modifications of RNA can occur ⁶, with N⁶-methyladenosine (m⁶A) being the most abundant and prevalent chemical modification made. This dynamic and reversible modification is regulated by the methyltransferase (methyltransferase like 3(METTL3), methyltransferase like 14༈METTL14༉, and wilms’ tumor 1-associating protein༈WTAP༉, called “writers”), demethylase (fat mass- and obesity- associated protein༈FTO༉ and a-ketoglutarate-dependent dioxygenase alkB homolog 5༈ALKBH5༉, called “erasers”), and RNA-binding proteins (e.g., the YTH domain-containing family༈YTH family༉, called “readers”) ^{7, 8}. Several investigations have demonstrated that m⁶A regulates mRNA stability ⁹, translation ¹⁰, nuclear export ¹¹, and decay ¹² and participates in many biological processes ^13–16. Of note, m⁶A levels change during organ maturation and early life processes ^17–19, and several investigations have suggested a temporal progression of m⁶A modification of different tissues and different stages of life ^{20, 21}. Despite these prospects, the dynamic m⁶A changes in lung or pulmonary vascular diseases remain to be elucidated.

In addition to hypoxia-induced changes in pulmonary function, several investigations have shown that epigenetic modifications, including DNA methylation and histone modification, play a vital role in the development of pulmonary diseases ^{22, 23}. While many investigations have provided insight into the epigenetic mechanisms of PH, few have focused on RNA modifications and their impacts on the development of this disease ²⁴. Recent investigations suggest that environmental factors in early life could predispose individuals to PH via epigenetic mechanisms ²⁵. However, whether RNA modifications are associated with the development of PH following postnatal exposure to hypoxia remains unknown.

Considering the essential role of m⁶A in tissue structure and function throughout life and the potential for postnatal exposure to hypoxia to alter lung development, the purpose of this investigation was to assess the impact of postnatal exposure to hypoxia on long-term lung maturation, the development of PH, and the role of m⁶A in these changes. We tested the two-fold hypothesis that 1) postnatal exposure to hypoxia would alter lung development leading to PH in adult rats and 2) m⁶A modifications would be altered in rats exposed to hypoxia. Using a postnatal hypoxia rat model, we assessed pulmonary arterial pressure and evaluated pulmonary vasculature function. We also performed methylated RNA immunoprecipitation sequencing (MeRIP-seq) to confirm the potential role of m⁶A in pulmonary vascular function following exposure to hypoxia.

Ethical approval and animal care

Sprague-Dawley rats were purchased from the Slaccas Company (Shanghai, China) and bred in our laboratory. The hypoxia model was established in a hypoxia chamber (Biospherix, USA). The pups assigned to the hypoxia group (n = 24) were exposed to hypoxia (F_iO₂ 11–12%) within 24 h after birth for 2 weeks before being returned to normoxic conditions. The control group (n = 16) lived under normoxic conditions throughout their life. All animals were sacrificed using 10% chloral hydrate at either 2 weeks or 9 weeks old. The right lung tissue was removed and then transferred to liquid nitrogen immediately. The left lung was fixed in 10% formalin for at least 48 hours before being cut for slides.

Pulmonary arterial pressure assessment

Prior to euthanasia, right ventricular systolic pressure (RVSP) was measured in 2-week-old rats and mean pulmonary arterial pressure (mPAP) in 9-week-old rats as described previously ²⁶. Briefly, in 2-week-old anesthetized rats, tracheal intubation was performed, and the thorax was opened. A catheter was then inserted into the right ventricle to measure the right ventricular pressure. For the measurement of mPAP (9 weeks), a PE50 catheter was inserted into the pulmonary artery via the jugular vein and the right heart to measure pulmonary arterial pressures. RVSP or mPAP was recorded when the waveform was stable. The Fulton index [RV / (LV + S)] was also used to determine the degree of cardiac remodeling, where RV represents the weight of the right ventricle and (LV + S) represents the weight of the left ventricle plus septum.

Hematoxylin-eosin staining (HE) and Immunohistochemical staining (IHC)

Pulmonary pathological changes were analyzed by HE and IHC, as described in detail previously ³. The paraffin blocks were cut into sections of 5 µm thickness. The primary antibodies used in IHC were anti-α-SMA (1:500, Servicebio, China).

Pulmonary vascular endothelial cells (PVECs) separation

Magnetic activated cell sorting (MACS) was used to separate PVECs from lung tissue. The required reagents and consumables were purchased from Miltenyi (Germany), and the extraction steps were performed according to the manufacturer’s instructions. Separated cells were frozen at − 80 °C for further use.

Quantitative real-time PCR (qPCR)

Lung tissue total RNA was isolated using a Multisource RNA Miniprep kit (Axygen, USA). The total RNA was reverse transcribed into cDNA using PrimeScript™ RT Master Mix (Perfect Real Time) Kit (Takara, China). qPCR was performed using an ABI Prism 7500 instrument following the SYBR-Green reagent protocol (Takara, China). Data were analyzed as fold change by the 2^−ΔΔCt method. Primers used in this study are listed below: β-actin forward: 5’-gccaaccgtgaaaagatg-3’, β-actin reverse: 5’-tgccagtggtacgaccag-3’; Rras2 forward: 5’-gaccatggcttttgcttgct-3’, Rras2 reverse: 5’-tagcggggacattgaacgtg-3’; Ttll12 forward: 5’-gcatccagagagttcgcaga-3’, Ttll12 reverse: 5’-gggtctcgggtgtaacacag-3’;

Protein and western blot

Lung tissue was lysed in a RIPA buffer (Beyotime Biotechnology, China) with PMSF (Thermo Fisher, USA); and a phosphatase inhibitor cocktail (Thermo Fisher, USA) was also added to the RIPA buffer when p-eNOS was to be analyzed. The lysate was then centrifuged for 10 min at 12000 g, and the supernatant was collected. An enhanced BCA protein assay kit (Beyotime Biotechnology, China) was used to measure the protein concentration. A 10% SDS-PAGE gel was used for electrophoresis, and the electrotransfer occurred for 90 min at 110 V with 0.45 µm PVDF membranes (Merck Millipore, USA). The membranes were incubated with antibodies, and a chemiluminescence method was used for color development. The G:BOX system (Syngene, USA) was used to generate gray-scale images. Image-Pro Plus software (Media Cybernetics, USA) was used to quantify the amount of protein as gray value. The primary antibodies used in the western blots were as follows: anti-METTL3 (1:1000, Abcam, UK), anti-METTL14 (1:2000, Cell Signaling Technology, USA), anti-WTAP (1:1000, Cell Signaling Technology), anti-FTO (1:1000, Abcam), anti-ALKBH5 (1:500, Proteintech, USA), anti-VEGF (1:200, Proteintech), anti-eNOS (1:1000, Cell Signaling Technology), anti-p-eNOS (1:1000, Cell Signaling Technology), and anti-β-actin (1:5000, Sigma-Aldrich, USA).

Total RNA m⁶A level detection

We used an EpiQuik™ m⁶A RNA Methylation Quantification Kit (Colorimetric) (Epigentek, USA) to determine the total m⁶A level in the lung tissue. The main procedure included three steps: RNA combination, m⁶A RNA capturing, and absorbance detection. The total m⁶A level was calculated using formulas provided in the kit.

Methylated RNA Immunoprecipitation sequencing (MeRIP-seq)

MeRIP was based on the m⁶A-seq protocol ²⁷. In brief, RNA samples were purified and then fragmented into 100 nt through chemical fragmentation. We then used anti-m⁶A antibodies to immunocapture m⁶A-modified RNA fragments. After elution with free m⁶A, library preparation and massively parallel sequencing was performed.

MeRIP data analysis

Distributions of peaks and motifs were analyzed using MACS2 and HOMER software. Gene Ontology (GO) analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis were applied to analyze differentially expressed genes (DEGs) related to m⁶A modification. GO analysis was used to classify DEG functions into biological process, molecular function, and cellular component. KEGG analysis was performed to identify the pathways the DEGs were enriched in.

Statistical analysis

All results were obtained from at least three biological replicates and shown as means ± standard error of the mean (means ± SEM). GraphPad Prism 6.0 and SPSS 23.0 were used for statistical analyses. The Student’s t-test was used to analyze the difference between independent samples. Comparisons were considered statistically significant when the P-value was < 0.05.

Postnatal hypoxia dysregulates lung development and leads to PH

Lung/body wet weight ratio increased after 2 weeks of exposure to hypoxia (hypoxia vs. control groups: 2.03 ± 0.05% vs. 1.25 ± 0.01%), suggesting that pulmonary edema occurred in the hypoxia group. RVSP (23.47 ± 0.44 mmHg vs. 14.91 ± 0.88 mmHg) and RV/(LV + S) (36.78 ± 1.44% vs. 21.73 ± 1.24%) were both significantly increased, suggesting that postnatal hypoxia caused pulmonary hypertension and the associated remodeling of cardiac tissue (Fig. 1A–C). The HE staining revealed underdeveloped pulmonary alveoli following exposure to hypoxia (Fig. 1D&E). The mean alveolar number (MAN) suggested that the development of alveoli in the hypoxia group was delayed when compared to controls. α-SMA immunostaining indicated that the pulmonary arterial intima was thickened in the hypoxia group (Fig. 1D&F). We also assessed the expression of endothelial nitric oxide synthase (eNOS) and vascular endothelial growth factor (VEGF), which play essential roles in the development of PH (Fig. 1G). The two proteins were both highly expressed in the lung tissue of the hypoxia group. Collectively, postnatal hypoxia of newborn rats dysregulated lung development and led to PH.

Postnatal hypoxia decreased the expression of m⁶A related proteins

To further explore m⁶A methylation after exposure to postnatal hypoxia, we determined the expression of five m⁶A-related proteins in lung tissue. A decrease in the m⁶A methyltransferases METTL3 and METTL14 was found (Fig. 2A, C&D). The demethylase proteins FTO and ALKBH5 were also decreased following postnatal hypoxia (Fig. 2B, E&F), but the expression of WTAP was not different between groups (data not shown). There was no clear impact of postnatal hypoxia on total m⁶A in the lung tissue (Fig. 2G).

Postnatal hypoxia changed the m⁶A methylation in lung tissue

MeRIP was then utilized to assess the specific m⁶A methylation changes following hypoxia. We identified 9488 methylated poly(A) peaks in the control group and 9842 in the hypoxia group (Fig. 3A). By comparing the m⁶A methylation peaks in the two groups, we found that 21 peaks were hyper-methylated, and 5 peaks were hypo-methylated in the hypoxia group (Fig. 3B). Then we performed GO analysis to identify the possible functions of the genes related to these differential peaks. As shown in Fig. 3C, these genes acted in many biological processes associated with organ morphogenesis and development. Data showed three of them participated in lung development, respiratory tube development, and respiratory system development.

Further verification was done by qPCR as we tested four differential peak-related genes (Rras2, Ttll12, Ccr3, and Ccr6) with known contributions to lung diseases. mRNA levels from two genes (Rras2 and Ttll12) changed in coordination with their m⁶A modification (Fig. 3D). In summary, m⁶A methylation participates in the regulation of vascular-related gene expression following postnatal hypoxia.

The long-term effect of postnatal hypoxia on pulmonary vascular in adult rat

To assess the influence of postnatal hypoxia on pulmonary function in adulthood, we measured the lung/body wet weight ratio, RV/(LV + S), and mPAP in 9-week-old rats. We found that the lung/body wet weight ratio, RV/(LV + S), and mPAP were significantly higher in the hypoxia group than in the controls (Fig. 4A–C). These results suggest that postnatal hypoxia-induced PH could continue to adulthood.

Western blot was used to assess eNOS and VEGF protein levels. VEGF and phosphorylated endothelial nitric oxide synthase (p-eNOS) were lower in the hypoxia group than in the controls (Fig. 4D, G&H), although there was no difference in eNOS protein expression between the two groups (Fig. 4D&E). Also, the expression of eNOS in PVECs was lower in the hypoxia group than in the controls (Fig. 4D&F). These results suggest that pulmonary vasculature dysfunction perpetuates in adult rats that have experienced postnatal hypoxia.

The long-term effect of postnatal hypoxia on m⁶A methylation in the adult rat

The expression of five m⁶A-related proteins during adulthood was measured in lung tissue from both groups. METTL3 was lower in the hypoxia group than in the controls (Fig. 5A), but there were no differences in the other four m⁶A-related proteins between the groups (data not shown).

Next, we performed MeRIP again to find the between-group specific m⁶A methylation changes. Although there were only 7 peaks hyper-methylated and 13 peaks hypo-methylated in the adult rats who were exposed to postnatal hypoxia (Fig. 5B), these differential peak-related genes were genes involved in the regulation of Notch signal pathways and the activation of endothelial cells (Fig. 5C).

The present investigation explored the acute and long-term impacts of postnatal hypoxia on pulmonary vascular function and remodeling and the role of m⁶A in the development of PH. Consistent with our original hypothesis, postnatal exposure to hypoxia resulted in significant remodeling of the pulmonary vasculature, increased mPAP, and reduced levels of m⁶A-related proteins. The reduced METTL3 expression was sustained into adulthood. These results suggest that m⁶A modification might be involved in the PH pathological process initiated by postnatal exposure to hypoxia.

Based on many epidemiological reports, the Developmental Origins of Health and Disease (DOHaD) theory suggests that exposure to adverse environmental factors (e.g., poor diet, stress, or infection) early in life can increase the likelihood of chronic diseases in adulthood. Recent reports found that transient hypoxemia during the perinatal period can increase pulmonary vasoconstriction during hypoxia exposure in adulthood ²⁸. Previous work from our laboratory showed that both IUGR and EUGR led to an exacerbated response to hypoxia and the development of PH in adult rats^1–3. The results from this investigation are in agreement with the findings from previous studies, and therefore support the premise that pulmonary vascular disease in adulthood is closely related to environmental factors in early life.

Postnatal exposure to hypoxia alters pulmonary vascular function

PH is a progressive disease consisting of multi-factorial pathogeny, which results in right heart failure with poor prognosis ²⁹. It is well established that there is an interaction between hypoxia and PH, thus underscoring the importance of understanding the complex interactions between hypoxia and the development of pulmonary diseases. NO signaling pathways play a key role in hypoxic pulmonary hypertension ³⁰. In animal models of chronic hypoxia in adulthood, the expression of eNOS protein increases after hypoxia. However, the expression of eNOS in neonatal rats after hypoxia is still unclear. Chicoine et al. found that chronic hypoxia in neonatal rats led to a decreased expression of eNOS protein ³¹. Whereas Sheak et al. showed that the expression of eNOS protein in neonatal rats did not change after hypoxia, but the expression of p-eNOS increased ³². In the present investigation, eNOS increased following postnatal exposure to hypoxia but decreased in the adult rat. This change could suggest that eNOS expression increased when PVECs were exposed to hypoxia. However, as PH progressed, PVECs became dysfunctional even under a normoxic state and they produced less eNOS. Regulated by a variety of molecules and pathways such as VEGF, the dysfunction of PVECs plays a key role in the development of PH ³³. VEGF promotes angiogenesis and the proliferation, migration, and differentiation of endothelial cells by binding to the vascular endothelial growth factor receptor 2(VEGFR2)on the pulmonary vascular endothelium ³². Consistent with previous investigations³⁴, these results demonstrated a consistent expression of VEGF and p-eNOS, which further suggests that VEGF is regulated by eNOS activity. VEGF can also affect eNOS phosphorylation, which likely alters local NO bioavailability and vasodilator signaling. These findings indicate that the mutual regulation between VEGF and p-eNOS is involved in the regulation of adult pulmonary vascular function following postnatal hypoxia.

Potential role of m⁶A in the development of hypoxia-induced PH

Compelling evidence suggests that epigenetic modification plays an essential role in the development of PH ³⁵. In our previous study, we discovered that the binding of histone acetylation and hypoxia-inducible factor-1α (HIF-1α) to the endothelin-1(ET-1) gene promoter increased in PAH following IUGR ³. We also demonstrated the epigenetic regulation of Notch1 in the pulmonary microvascular rarefaction following EUGR ². Another study found that nitric oxide synthase༈NOS༉ upregulation was associated with increased H3 and H4 histone acetylation in the eNOS promoter in a neonatal rodent persistent pulmonary hypertension of the newborn༈PPHN༉ model ²⁵. However, the epigenetic regulation of these factors in mammals and whether m⁶A mediates PH remains unknown. Since m⁶A is a common chemical modification of RNAs in mammals, it functions in various vital biological pathways such as tumorigenesis ^{5, 36} and embryonic^{13, 37} and neuronal development ^{21, 38}. Considerable attention has been given to the essential role of m⁶A in embryonic development and spermatogenesis ¹⁵. Still, there is little focus on the function of m⁶A in the lung or pulmonary vascular disease development.

We hypothesized that m⁶A also participates in PH following postnatal exposure to hypoxia. m⁶A methyltransferase and demethylase proteins exhibited lower levels in the postnatal hypoxia group than in the controls, while the total level of m⁶A in lung tissue was not affected by postnatal hypoxia. Among m⁶A-related proteins, WTAP levels did not change. This might be related to the fact that WTAP has no methyltransferase activity. Instead, it regulates m⁶A levels by combining with METTL3 / METTL14 complex ³⁹. Future investigations should seek to identify other m⁶A-related proteins, which may help identify the specific role that m⁶A plays in the pathogenesis of hypoxia-induced PH.

METTL3 expression was consistently lower in the hypoxia group than in the controls. METTL3 participates in the development of tumors and the development of early embryos by regulating m⁶A modification ^40–42. In a recent investigation⁴³, METTL3 expression was significantly upregulated in patients with lung adenocarcinoma. Cytological experiments have demonstrated that METTL3 affects the growth, survival, and invasion of human lung cancer cells ⁴³, which implies that METTL3 plays an important role in the long-term effects on pulmonary vasculature function following postnatal exposure to hypoxia.

The present investigation utilized MeRIP to analyze the specific m⁶A methylation changes following exposure to hypoxia. We found 21 hyper-methylated and 5 hypo-methylated peaks in 2-week-old rats exposed to hypoxia. In comparison, 7 peaks were hyper-methylated, and 13 peaks were hypo-methylated in adult rats who had suffered from postnatal hypoxia. While these might not seem like a significant finding, these differential peak-related genes are involved in many respiratory-related physiological processes such as respiratory tube development, Notch signal pathways, and the activation of endothelial cells. Thus, it is likely that m⁶A participates in the pathogenesis of PH. Interestingly, we found that the tricho-rhino-phalangeal syndrome 1 (Trps1) gene was hypomethylated in both the 2-week-old and 9-week-old rats who were exposed to postnatal hypoxia. TRPS1, a member of the GATA transcription factor family, is widely expressed in many tissues and organs and plays a critical role in mammalian development and differentiation ^{44, 45}. TRPS1 is also highly expressed in lung cancer⁴⁶ and is involved in regulating epithelial-to-mesenchymal transition (EMT) during embryonic development⁴⁷. While EMT plays an important role in the occurrence and development of PH ⁴⁸, it has not been reported whether Trps1 is also involved in the regulation of PH pathogenesis. Our results suggest that Trps1 mRNA methylation can regulate PH following postnatal hypoxia by affecting EMT in the newborn rat, and this effect can persist into adulthood. Future investigations will identify the specific role(s) of EMT in the development of hypoxia-induced PH.

Experimental considerations and future directions

While this investigation demonstrated that postnatal exposure to hypoxia impacts pulmonary vascular function and development, it is unclear if this results in impaired functional capacity (i.e., exercise tolerance) of these animals. Considering that pulmonary hypertension leads to reduced maximal oxygen uptake and exercise capacity in humans ⁴⁹, it is likely that the impaired pulmonary vascular function in rats exposed to postnatal hypoxia studied herein would have reduced exercise capacity. Future investigations into the interplay between postnatal hypoxia-induced PH and reduced exercise tolerance may aid in the bench-to-bedside translation of our understanding of this disease and the associated molecular mechanisms.

This investigation sheds light on the long-term effect of postnatal exposure to hypoxia on pulmonary vascular functions and the role of m⁶A in regulating PH. These results suggest that m⁶A methylation is a biomarker of epigenetic modification of critical genes that regulate pulmonary arterial pressure and lung development and, therefore, may be potential therapeutic targets. However, additional investigations are required to delineate the specific regulatory mechanisms between m⁶A and PH and test the possibilities of regulating m⁶A methylation to treat PH.

To summarize, this investigation demonstrated that postnatal hypoxia dysregulates long-term lung development, leads to PH, and has a long-term effect on adult rat lung via persistent dysregulation of pulmonary vascular function. Our data show that m⁶A modification changes are associated with PH following postnatal hypoxia and that some changes can persist into adulthood. These findings indicate that m⁶A methylation might participates in the development of PH following postnatal hypoxia. Our research offers a new perspective to explain the molecular mechanism of lung diseases and provides a reference for future investigations into therapeutic development.

ALKBH5	a-ketoglutarate-dependent dioxygenase alkB homolog 5
DEGs	differentially expressed genes
DOHaD	developmental origins of health and disease
EMT	epithelial-to-mesenchymal transition
eNOS	endothelial nitric oxide synthase
ET-1	endothelin-1
EUGR	extrauterine growth retardation
FTO	fat mass- and obesity- associated protein
GO analysis	Gene Ontology analysis
HE	hematoxylin-eosin staining
HIF-1α	hypoxia-inducible factor-1α
IHC	immunohistochemical staining
IUGR	intrauterine growth retardation
KEGG analysis	Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis
m⁶A	N⁶-methyladenosine
MACS	magnetic activated cell sorting
MAN	mean alveolar number
MeRIP-seq	methylated RNA immunoprecipitation sequencing
METTL14	methyltransferase like 14
METTL3	methyltransferase like 3
mPAP	mean pulmonary arterial pressure
NOS	nitric oxide synthase
PAH	pulmonary arterial hypertension
p-eNOS	phosphorylated endothelial nitric oxide synthase
PH	pulmonary hypertension
PPHN	persistent pulmonary hypertension of the newborn
PVECs	pulmonary vascular endothelial cells
qPCR	quantitative real-time PCR
RVSP	right ventricular systolic pressure
VEGF	vascular endothelial growth factor
VEGFR2	vascular endothelial growth factor receptor 2
WTAP	wilms’ tumor 1-associating protein
YTH family	YTH domain-containing family
α-SMA	smooth muscle specific alpha-actin antibody

Ethics approval and consent to participate

This study followed the national guidelines and protocols of the National Institutes of Health and was approved by the Local Ethics Committee for the Care and Use of Laboratory Animals of Zhejiang University.

Consent for publication

Not applicable.

Availability of data and materials

The datasets used and analyzed during the current study are available from the corresponding author on reasonable request.

Competing interests

None.

Sources of Funding

This work was supported by the National Natural Science Foundation of China [grant numbers 81471480, 81630037 and 81871220].

Author contributions

LD and XX conceived and designed the study. SX, ZZ and LY performed the study. SX and LZ analyzed the data. SX was a major contributor in writing the manuscript. All authors read and approved the final manuscript.

Acknowledgments

We also thank the Zhejiang Key Laboratory for Diagnosis and Therapy of Neonatal Diseases for assistance in histopathology and data analysis.

Zhang L, Tang L, Wei J, Lao L, Gu W, Hu Q, Lv Y, Fu L and Du L. Extrauterine growth restriction on pulmonary vascular endothelial dysfunction in adult male rats: the role of epigenetic mechanisms. J Hypertens. 2014;32:2188-98.
Tang LL, Zhang LY, Lao LJ, Hu QY, Gu WZ, Fu LC and Du LZ. Epigenetics of Notch1 regulation in pulmonary microvascular rarefaction following extrauterine growth restriction. Respir Res. 2015;16:66.
Xu X-F, Lv Y, Gu W-Z, Tang L-L, We J-K, Zhang L-Y and Du L-Z. Epigenetics of hypoxic pulmonary arterial hypertension following intrauterine growth retardation rat epigenetics in PAH following IUGR. Respir Res. 2013;14:20.
Panneerdoss S, Eedunuri VK, Yadav P, Timilsina S, Rajamanickam S, Viswanadhapalli S, Abdelfattah N, Onyeagucha BC, Cui X, Lai Z, A.Mohammad T, Gupta YK, Huang TH-M, Huang Y, Chen Y and Rao MK. Cross-talk among writers, readers, and erasers of m6A regulates cancer growth and progression. Sci Adv. 2018;4:eaar8263.
Hong K. Emerging function of N6‑methyladenosine in cancer (Review). Oncology Letters. 2018;16:5519-5524.
Desrosiers R, Friderici K and Rottman F. Identification of methylated nucleosides in messenger RNA from Novikoff hepatoma cells. Proc Natl Acad Sci U S A. 1974;71:3971-5.
Niu Y, Zhao X, Wu YS, Li MM, Wang XJ and Yang YG. N6-methyl-adenosine (m6A) in RNA: an old modification with a novel epigenetic function. Genomics Proteomics Bioinformatics. 2013;11:8-17.
Yue Y, Liu J and He C. RNA N6-methyladenosine methylation in post-transcriptional gene expression regulation. Genes Dev. 2015;29:1343–1355.
Wang X, Lu Z, Gomez A, Hon GC, Yue Y, Han D, Fu Y, Parisien M, Dai Q, Jia G, Ren B, Pan T and He C. N6-methyladenosine-dependent regulation of messenger RNA stability. Nature. 2014;505:117-20.
Wang X, Zhao BS, Roundtree IA, Lu Z, Han D, Ma H, Weng X, Chen K, Shi H and He C. N(6)-methyladenosine Modulates Messenger RNA Translation Efficiency. Cell. 2015;161:1388-99.
Roundtree IA, Luo GZ, Zhang Z, Wang X, Zhou T, Cui Y, Sha J, Huang X, Guerrero L, Xie P, He E, Shen B and He C. YTHDC1 mediates nuclear export of N(6)-methyladenosine methylated mRNAs. eLife. 2017;6:e31311.
Shi H, Wang X, Lu Z, Zhao BS, Ma H, Hsu PJ, Liu C and He C. YTHDF3 facilitates translation and decay of N(6)-methyladenosine-modified RNA. Cell Res. 2017;27:315-328.
Batista PJ, Molinie B, Wang J, Qu K, Zhang J, Li L, Bouley DM, Lujan E, Haddad B, Daneshvar K, Carter AC, Flynn RA, Zhou C, Lim KS, Dedon P, Wernig M, Mullen AC, Xing Y, Giallourakis CC and Chang HY. m(6)A RNA modification controls cell fate transition in mammalian embryonic stem cells. Cell Stem Cell. 2014;15:707-19.
Fustin JM, Doi M, Yamaguchi Y, Hida H, Nishimura S, Yoshida M, Isagawa T, Morioka MS, Kakeya H, Manabe I and Okamura H. RNA-methylation-dependent RNA processing controls the speed of the circadian clock. Cell. 2013;155:793-806.
Lin Z, Hsu PJ, Xing X, Fang J, Lu Z, Zou Q, Zhang KJ, Zhang X, Zhou Y, Zhang T, Zhang Y, Song W, Jia G, Yang X, He C and Tong MH. Mettl3-/Mettl14-mediated mRNA N(6)-methyladenosine modulates murine spermatogenesis. Cell Res. 2017;27:1216-1230.
Engel M, Eggert C, Kaplick PM, Eder M, Roh S, Tietze L, Namendorf C, Arloth J, Weber P, Rex-Haffner M, Geula S, Jakovcevski M, Hanna JH, Leshkowitz D, Uhr M, Wotjak CT, Schmidt MV, Deussing JM, Binder EB and Chen A. The Role of m(6)A/m-RNA Methylation in Stress Response Regulation. Neuron. 2018;99:389-403 e9.
Chang M, Lv H, Zhang W, Ma C, He X, Zhao S, Zhang ZW, Zeng YX, Song S, Niu Y and Tong WM. Region-specific RNA m(6)A methylation represents a new layer of control in the gene regulatory network in the mouse brain. Open Biol. 2017;7:170166.
Wang CX, Cui GS, Liu X, Xu K, Wang M, Zhang XX, Jiang LY, Li A, Yang Y, Lai WY, Sun BF, Jiang GB, Wang HL, Tong WM, Li W, Wang XJ, Yang YG and Zhou Q. METTL3-mediated m6A modification is required for cerebellar development. PLoS Biol. 2018;16:e2004880.
Zhao BS, Wang X, Beadell AV, Lu Z, Shi H, Kuuspalu A, Ho RK and He C. m(6)A-dependent maternal mRNA clearance facilitates zebrafish maternal-to-zygotic transition. Nature. 2017;542:475-478.
Meyer KD, Saletore Y, Zumbo P, Elemento O, Mason CE and Jaffrey SR. Comprehensive analysis of mRNA methylation reveals enrichment in 3' UTRs and near stop codons. Cell. 2012;149:1635-46.
Ma C, Chang M, Lv H, Zhang ZW, Zhang W, He X, Wu G, Zhao S, Zhang Y, Wang D, Teng X, Liu C, Li Q, Klungland A, Niu Y, Song S and Tong WM. RNA m(6)A methylation participates in regulation of postnatal development of the mouse cerebellum. Genome Biol. 2018;19:68.
Ito K, Ito M, Elliott WM, Cosio B, Caramori G, Kon OM, Barczyk A, Hayashi S, Adcock IM, Hogg JC and Barnes PJ. Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N Engl J Med. 2005;352:1967-76.
Cosio BG, Mann B, Ito K, Jazrawi E, Barnes PJ, Chung KF and Adcock IM. Histone acetylase and deacetylase activity in alveolar macrophages and blood mononocytes in asthma. Am J Respir Crit Care Med. 2004;170:141-7.
Saco TV, Parthasarathy PT, Cho Y, Lockey RF and Kolliputi N. Role of epigenetics in pulmonary hypertension. Am J Physiol Cell Physiol. 2014;306:C1101-5.
Xu XF, Ma XL, Shen Z, Wu XL, Cheng F and Du LZ. Epigenetic regulation of the endothelial nitric oxide synthase gene in persistent pulmonary hypertension of the newborn rat. J Hypertens. 2010;28:2227-35.
Wu X, Du L, Xu X, Tan L and Li R. Increased Nitrosoglutathione Reductase Activity in Hypoxic Pulmonary Hypertension in Mice. Journal of Pharmacological Sciences. 2010;113:32-40.
Dominissini D, Moshitch-Moshkovitz S, Salmon-Divon M, Amariglio N and Rechavi G. Transcriptome-wide mapping of N(6)-methyladenosine by m(6)A-seq based on immunocapturing and massively parallel sequencing. Nat Protoc. 2013;8:176-89.
O'Callaghan DS, Savale L, Montani D, Jais X, Sitbon O, Simonneau G and Humbert M. Treatment of pulmonary arterial hypertension with targeted therapies. Nat Rev Cardiol. 2011;8:526-38.
Ranchoux B, Harvey LD, Ayon RJ, Babicheva A, Bonnet S, Chan SY, Yuan JX and Perez VJ. Endothelial dysfunction in pulmonary arterial hypertension: an evolving landscape (2017 Grover Conference Series). Pulm Circ. 2018;8:2045893217752912.
He Q, Liu X, Zhong Y, Xu SS, Zhang ZM, Tang LL, Zhang LY and Du LZ. Arginine bioavailability and endothelin-1 system in the regulation of vascular function of umbilical vein endothelial cells from intrauterine growth restricted newborns. Nutrition, Metabolism and Cardiovascular Diseases. 2018;28:1285-1295.
CHICOINE LG, AVITIA JW, DEEN C, NELIN LD, EARLEY S and WALKER BR. Developmental differences in pulmonary eNOS expression in response to chronic hypoxia in the rat. J Appl Physiol. 2002;93:311-318.
Sheak JR, Weise-Cross L, deKay RJ, Walker BR, Jernigan NL and Resta TC. Enhanced NO-dependent pulmonary vasodilation limits increased vasoconstrictor sensitivity in neonatal chronic hypoxia. Am J Physiol Heart Circ Physiol. 2017;313:H828-H838.
MORTOLA JP, XU L and LAUZON A-M. Body growth, lung and heart weight, and DNA content in newborn rats exposed to different levels of chronic hypoxia. Can J Physiol Pharmacol. 1990;68.
Liu Y, Paterson M, Baumgardt SL, Irwin MG, Xia Z, Bosnjak ZJ and Ge ZD. Vascular endothelial growth factor regulation of endothelial nitric oxide synthase phosphorylation is involved in isoflurane cardiac preconditioning. Cardiovasc Res. 2019;115:168-178.
Kim GH, Ryan JJ, Marsboom G and Archer SL. Epigenetic mechanisms of pulmonary hypertension. Pulm Circ. 2011;1:347-56.
Li Z, Weng H, Su R, Weng X, Zuo Z, Li C, Huang H, Nachtergaele S, Dong L, Hu C, Qin X, Tang L, Wang Y, Hong GM, Huang H, Wang X, Chen P, Gurbuxani S, Arnovitz S, Li Y, Li S, Strong J, Neilly MB, Larson RA, Jiang X, Zhang P, Jin J, He C and Chen J. FTO Plays an Oncogenic Role in Acute Myeloid Leukemia as a N(6)-Methyladenosine RNA Demethylase. Cancer Cell. 2017;31:127-141.
Mendel M, Chen KM, Homolka D, Gos P, Pandey RR, McCarthy AA and Pillai RS. Methylation of Structured RNA by the m(6)A Writer METTL16 Is Essential for Mouse Embryonic Development. Mol Cell. 2018;71:986-1000 e11.
Lence T, Akhtar J, Bayer M, Schmid K, Spindler L, Ho CH, Kreim N, Andrade-Navarro MA, Poeck B, Helm M and Roignant JY. m(6)A modulates neuronal functions and sex determination in Drosophila. Nature. 2016;540:242-247.
Liu J, Yue Y, Han D, Wang X, Fu Y, Zhang L, Jia G, Yu M, Lu Z, Deng X, Dai Q, Chen W and He C. A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation. Nat Chem Biol. 2014;10:93-5.
Wu Y, Xie L, Wang M, Xiong Q, Guo Y, Liang Y, Li J, Sheng R, Deng P, Wang Y, Zheng R, Jiang Y, Ye L, Chen Q, Zhou X, Lin S and Yuan Q. Mettl3-mediated m(6)A RNA methylation regulates the fate of bone marrow mesenchymal stem cells and osteoporosis. Nat Commun. 2018;9:4772.
Chen M, Wei L, Law CT, Tsang FH, Shen J, Cheng CL, Tsang LH, Ho DW, Chiu DK, Lee JM, Wong CC, Ng IO and Wong CM. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2. Hepatology. 2018;67:2254-2270.
Barbieri I, Tzelepis K, Pandolfini L, Shi J, Millan-Zambrano G, Robson SC, Aspris D, Migliori V, Bannister AJ, Han N, De Braekeleer E, Ponstingl H, Hendrick A, Vakoc CR, Vassiliou GS and Kouzarides T. Promoter-bound METTL3 maintains myeloid leukaemia by m(6)A-dependent translation control. Nature. 2017;552:126-131.
Lin S, Choe J, Du P, Triboulet R and Gregory RI. The m(6)A Methyltransferase METTL3 Promotes Translation in Human Cancer Cells. Mol Cell. 2016;62:335-345.
H.Malik T, A.Shoichet S, Latham P, G.Kroll T and A.Shivdasani R. Transcriptional repression and developmental functions of the atypical vertebrate GATA protein TRPS1. the EMBO Journal. 2001;20:1715-1725.
Suemoto H, Muragaki Y, Nishioka K, Sato M, Ooshima A, Itoh S, Hatamura I, Ozaki M, Braun A, Gustafsson E and Fassler R. Trps1 regulates proliferation and apoptosis of chondrocytes through Stat3 signaling. Dev Biol. 2007;312:572-81.
Liu H, Liao Y, Tang M, Wu T, Tan D, Zhang S and Wang H. Trps1 is associated with the multidrug resistance of lung cancer cell by regulating MGMT gene expression. Cancer Med. 2018;7:1921-1932.
Su P, Hu J, Zhang H, Jia M, Li W, Jing X and Zhou G. Association of TRPS1 gene with different EMT markers in ERα-positive and ERα-negative breast cancer. Diagnostic Pathology. 2014;9.
Ranchoux B, Antigny F, Rucker-Martin C, Hautefort A, Pechoux C, Bogaard HJ, Dorfmuller P, Remy S, Lecerf F, Plante S, Chat S, Fadel E, Houssaini A, Anegon I, Adnot S, Simonneau G, Humbert M, Cohen-Kaminsky S and Perros F. Endothelial-to-mesenchymal transition in pulmonary hypertension. Circulation. 2015;131:1006-18.
Gläser S, Noga O, Koch B, Opitz CF, Schmidt B, Temmesfeld B, Dörr M, Ewert R and Schäper C. Impact of pulmonary hypertension on gas exchange and exercise capacity in patients with pulmonary fibrosis. Respir Med. 2009;103:317-24.

Download PDF

Journal Publication

published 26 Apr, 2021

Read the published version in Respiratory Research →

Editorial decision: Major revision
21 Feb, 2021
Review #2 received at journal
15 Feb, 2021
Review #1 received at journal
04 Feb, 2021
Reviewer #2 agreed at journal
27 Jan, 2021
Reviewer #1 agreed at journal
24 Jan, 2021
Reviewers invited by journal
23 Jan, 2021
Editor assigned by journal
19 Dec, 2020
Submission checks completed at journal
19 Dec, 2020
Editor invited by journal
19 Dec, 2020
First submitted to journal
17 Dec, 2020

You are reading this latest preprint version

The Role of RNA m⁶A Methylation in the Regulation of Postnatal Hypoxia-induced Pulmonary Hypertension

Status:

Journal Publication

Version 1

Abstract

Figures

Introduction

Methods

Pulmonary arterial pressure assessment

Hematoxylin-eosin staining (HE) and Immunohistochemical staining (IHC)

Pulmonary vascular endothelial cells (PVECs) separation

Quantitative real-time PCR (qPCR)

Protein and western blot

Total RNA m⁶A level detection

Methylated RNA Immunoprecipitation sequencing (MeRIP-seq)

MeRIP data analysis

Statistical analysis

Results

Postnatal hypoxia dysregulates lung development and leads to PH

Postnatal hypoxia decreased the expression of m⁶A related proteins

Postnatal hypoxia changed the m⁶A methylation in lung tissue

The long-term effect of postnatal hypoxia on pulmonary vascular in adult rat

The long-term effect of postnatal hypoxia on m⁶A methylation in the adult rat

Discussion

Postnatal exposure to hypoxia alters pulmonary vascular function

Potential role of m⁶A in the development of hypoxia-induced PH

Experimental considerations and future directions

Conclusions

List Of Abbreviations

Declarations

References

Status:

Journal Publication

Version 1

The Role of RNA m6A Methylation in the Regulation of Postnatal Hypoxia-induced Pulmonary Hypertension

Status:

Journal Publication

Version 1

Abstract

Figures

Introduction

Methods

Pulmonary arterial pressure assessment

Hematoxylin-eosin staining (HE) and Immunohistochemical staining (IHC)

Pulmonary vascular endothelial cells (PVECs) separation

Quantitative real-time PCR (qPCR)

Protein and western blot

Total RNA m6A level detection

Methylated RNA Immunoprecipitation sequencing (MeRIP-seq)

MeRIP data analysis

Statistical analysis

Results

Postnatal hypoxia dysregulates lung development and leads to PH

Postnatal hypoxia decreased the expression of m6A related proteins

Postnatal hypoxia changed the m6A methylation in lung tissue

The long-term effect of postnatal hypoxia on pulmonary vascular in adult rat

The long-term effect of postnatal hypoxia on m6A methylation in the adult rat

Discussion

Postnatal exposure to hypoxia alters pulmonary vascular function

Potential role of m6A in the development of hypoxia-induced PH

Experimental considerations and future directions

Conclusions

List Of Abbreviations

Declarations

References

Status:

Journal Publication

Version 1

The Role of RNA m⁶A Methylation in the Regulation of Postnatal Hypoxia-induced Pulmonary Hypertension

Total RNA m⁶A level detection

Postnatal hypoxia decreased the expression of m⁶A related proteins

Postnatal hypoxia changed the m⁶A methylation in lung tissue

The long-term effect of postnatal hypoxia on m⁶A methylation in the adult rat

Potential role of m⁶A in the development of hypoxia-induced PH